Not a barn burner, for sure. Although, it looks like the goal was to get some synergy with their other products. By having a more complete offering, perhaps they can increase sales of both the old and the new.
Also, GlycoMar seems to be largely an R&D outfit. Apparently, they sell products primarily to allow them to fund more research. I suspect they don't have the sales force available to NEOG, so I'm guessing there is a growth opportunity there, as well.
But, either way, NEOG has a pretty good track record with growing their business. I trust management to continue to make good decisions.
My take: It gives the Neogen Scots something else to do, adds to existing business and may improve penetration in seafood business. Lets the parent company, that sold the asset, focus on what they really wanted to do and they will continue ties to the sold asset. May expand penetration in markets where we don't currently have significant recognition. Like most minimal purchases to date it causes no digestive discomfort and probably will be acretive.